BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez MG, Combe E, Inchauspe A, Mangeot PE, Delberghe E, Chapus F, Neveu G, Alam A, Carter K, Testoni B, Zoulim F. CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants. mBio 2022;:e0288821. [PMID: 35389262 DOI: 10.1128/mbio.02888-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kayesh MEH, Hashem MA, Kohara M, Tsukiyama-kohara K. In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update. Front Microbiol 2022;13:953218. [DOI: 10.3389/fmicb.2022.953218] [Reference Citation Analysis]
2 Hong X, Hu J. Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation. J Virol 2022;:e0071822. [PMID: 35867543 DOI: 10.1128/jvi.00718-22] [Reference Citation Analysis]
3 Hawsawi YM, Shams A, Theyab A, Siddiqui J, Barnawee M, Abdali WA, Marghalani NA, Alshelali NH, Al-sayed R, Alzahrani O, Alqahtani A, Alsulaiman AM. The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19. Front Cell Infect Microbiol 2022;12:869889. [DOI: 10.3389/fcimb.2022.869889] [Reference Citation Analysis]